Glaukos

Glaukos Current Assets

The Current Assets of Glaukos (GKOS) as of Nov 1, 2026 is 366.38 M USD. In the previous year, Current Assets was 449.79 M USD — a change of -18.55% (lower).

Current Assets

366.38 MUSD

YoY

-18.55%

Last updated:

Current Assets of Glaukos is 2025 366.38 M USD. Current Assets of Glaukos was 2024 449.79 M USD. It decreases by -18.55% lower compared to the previous year.

The Glaukos Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
180.72 M USD
Jan 1, 2019
262.86 M USD
Jan 1, 2020
469.48 M USD
Jan 1, 2021
486.09 M USD
Jan 1, 2022
443.89 M USD
Jan 1, 2023
395.46 M USD
Jan 1, 2024
449.79 M USD
Jan 1, 2025
366.38 M USD
The Glaukos Current Assets history
YEARCurrent AssetsYoY
366.38 MUSD-18.55%
449.79 MUSD+13.74%
395.46 MUSD-10.91%
443.89 MUSD-8.68%
486.09 MUSD+3.54%
469.48 MUSD+78.61%
262.86 MUSD+45.45%
180.72 MUSD+18.84%
152.07 MUSD+26.71%
120.02 MUSD+15.30%
104.09 MUSD+886.08%
10.56 MUSD-11.79%
11.97 MUSD+235.21%
3.57 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Glaukos Stock analysis

What does Glaukos do? Glaukos Corp is a medical technology company specializing in developing devices and therapies for treating eye diseases. It was founded in 1998 by employees of the ophthalmology center at the University of California San Francisco. The company focuses on utilizing new technologies and therapies to improve the vision quality of patients. They have developed innovative products for diagnosing and treating various eye conditions, including glaucoma. Their core business involves manufacturing and distributing medical devices for glaucoma treatment, such as the iStent implant. They have also partnered with other institutions to advance research and development in the field of ophthalmology. In 2018, Glaukos Corp acquired the German manufacturer Markt II Medical, expanding their product offerings for a wider range of eye diseases. In summary, Glaukos Corp is an innovative medical technology company that aims to enhance patients' vision quality while minimizing the risks of eye surgery. Glaukos is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Glaukos stock

Current Assets of Glaukos is 366.38 M USD in 2025.

Current Assets of Glaukos changed from 449.79 M USD to 366.38 M USD, representing a -18.55% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Glaukos since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Glaukos historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Glaukos

All Key Metrics — Glaukos